The environment and sensitisation to allergens in early childhood

Pediatric Allergy and Immunology, Supplement

Volumn 8, Issue 10, 1997, Pages 32-39

  Björkstén, Bengt ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergens; Antibodies; Asthma; Eczema; Rhinitis; Tobacco; Wheezing

Indexed keywords

ALLERGEN;

ASTHMA; CHILDHOOD; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; PRIORITY JOURNAL; RHINITIS; SENSITIZATION; WHEEZING;

ALLERGENS; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; HUMANS; HYPERSENSITIVITY; INFECTION; LIFE STYLE; PREVALENCE; RISK FACTORS;

EID: 0031460764     PISSN: 09065784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. BURNEY P. Epidemiology of asthma. Allergy 1993: 48: 17-21.
2. BURR M, BUTLAND B, KING S, VAUGHAN-WILLIAMS E. Changes in asthma prevalence: Two surveys fifteen years apart. Arch Dis Child 1989: 64: 1452-6.
3. HOLT P. Postnatal maturation of immune competence during infancy and childhood. Pediatr Allergy Immunol 1995: 6: 59-70.
4. BJÖRKSTÉN B. Risk factors in early childhood for the development of atopic diseases. Allergy 1994: 49: 400-7.
5. HOLT P. Environmental factors and primary t-cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 1995: 6: 1-10.
6. PEARCE N, WEILAND S, KEIL U, et al. Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J 1993: 6: 1455-61,
7. WICHMANN H. Environment, life-style and allergy: the German answer. Allergo J 1995: 4: 315-16.
8. JÖGI R, JANSSON C, BJÖRNSSON E, BOMAN G, BJÖRKSTÉN B. The prevalence of athmatic respiratory symptoms among adults in an Estonian and Swedish university town. Allergy 1996: 51: 331-6.
9. HEDBERG A. National Swedish Board of Welfare, 1994.
10. CRONER S, KJELLMAN N-IM. Predictors of atopic disease: cord blood IgE and month of birth. Allergy 1986: 41: 68-70.
11. BJÖRKSTÉN B. Does breast feeding prevent the development of allergy? Immunol Today 1983: 4: 215-17.
12. ROMAGNANI S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res 1991: 21: 152-8.
13. MCMENAMIN C, HOLT PG. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of IgE production. J Exp Med 1993: 178: 889-99.
14. WARNER JA, MILES EA, JONES AC, QUINT DJ, COLWELL BM, WARNER JO. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994: 24: 423-30.
15. TANG M, KEMP A, THORBURN J, HILL D. Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet 1994: 344: 983-5.
16. RINAS U, HORNEFF G, WAHN V. Interferon-gamma production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE-levels. Pediatr Allergy Immunol 1993: 4: 60-4.
17. BJÖRKSTÉN B, BORRES M, EINARSSON R. Interleukin-4, soluble CD23, interferon-g levels in serum during the first 18 months of life. Int Arch Allergy Immunol 1995: 107: 34-6.
18. KEMENY DM, URBANEK R, EWAN P, et al. The subclass of IgG antibody in allergic disease: II. The IgG subclass of antibodies produced following natural exposure to dust mite and grass pollen in atopic and non-atopic individuals. Clin Exp Allergy 1989: 19: 545-9.
19. HATTEVIG G, KJELLMAN B, JOHANSSON SGO, BJORKSTÉN B. Clinical symptoms and IgE responses to common food proteins in atopic and healthy children. Clin Allergy 1984: 14: 551-9.
20. HATTEVIG G, KJELLMAN B, BJÖRKSTÉN B. Appearance of IgE antibodies to ingested and inhaled allergens during first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993: 4: 182-9.
21. WARNER J, JONES A, MILES E, COLWELL B, WARNER J. Matemofetal interaction and allergy. Allergy 1996: 51: 447-51.
22. VASSELLA C, ODELRAM H, KJELLMAN N-I, BORRES M, VANTO T, BJORKSTÉN B. High anti-IgE levels at birth are associated with a reduced allergy incidence in early childhood. Clin Exp Allergy 1994: 24: 771-7.
23. BJÖRKSTÉN B. Immunological interaction between the mother and her infant in relation to the development of food allergy. Int Arch Allergy Appl Immunol 1997: in press.
24. ALLARDYCE R. Breast milk cell supernatants from atopic donors stimulate cord blood IgA secretion in vitro. Clinical Allergy 1984: 14: 259-67.
25. PRENTICE A. Breast feeding increases concentrations of IgA in infants' urine. Arch Dis Child 1987: 62: 792-5.
26. SHIBA S, MINAGAWA T, MITO K, et al. Effect of breast feeding on responses of systemic interferon and virus-specific lymphocyte transformation in infants with respiratory syncytial virus infection. J Med Virol 1987: 21: 7-14.
27. SCHLESINGER J. Evidence for transmission of lymphocyte responses to tuberculin by breast-feeding. Lancet 1977: 1: 529-32.
28. SARFATI M, VANDERBEEKEN Y, RUBIO-TRUJILLO M, DUNCAN D. Presence of IgE suppressor factors in human colostrum. Eur J Immunol 1986: 16: 1005-8.
29. BJÖRKSTÉN B, FINNSTRÖM O, WICHMAN K. Intrauterine exposure to the beta-adrenergic receptor-blocking agent metoprolol and allergy. Int Arch Allergy Appl Immunol 1988: 87: 59-62.
30. PAUWELS R, BAZIN H, PLATTEAU B, VAN DER STRAETEN M. Influence of adrenergic drugs on reaginic antibody response in mice. Int Arch Allergy Appl Immunol 1980: 61: 347-51.
31. TAKAFUJI S, SUZUKI S, KOIZUMI K, et al. Diesel-exhaust particulates inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol 1987: 79: 639-45.
32. HALKEN S, HØST A, NILSSON L, TAUDORF E. Passive smoking as a risk factor for development of obstructive respiratory disease and allergic sensitization. Allergy 1995: 50: 97-105.
33. ABRAMSON M. Air pollution health effects and air quality objectives. Med J Australia 1991: 154: 716-17.
34. ÅBERG N. Birth season variation in asthma and allergic rhinitis. Clin Exp Allergy 1989: 19: 643-8.
35. MUNIR AKM, BJÖRKSTÉN B, EINARSSON R, et al. Mite allergens in relation to home conditions of asthmatic children from three climatic regions. Allergy 1995: 50: 55-64.
36. WICKMAN M, NORDVALL SL, PERSHAGEN G. Risk factors in early childhood for sensitization to airborne allergens. Pediatr Allergy Immunol 1992: 3: 128-33.
37. WELLIVER C, DUFFY L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing and pulmonary dysfunction at age 7-8 years. Pediatr Pulmonol 1993: 15: 19-27.
38. STRANNEGÅRD I-L, STRANNEGÅRD O̊. Epstein-Barr virus antibody in children with atopic disease. Int Arch Allergy Appl Immunol 1981: 64: 314-19.
39. SIGURS N, BJARNASON R, SIGURBERGSSON F, KJELLMAN B, BJÖRKSTÉN B. Asthma and IgE antibodies after Respiratory Syncytial Virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995: 95: 500-5.
40. PAUWELS R, VAN der STRAETEN M, PLATTEU B, BAZIN H. The non-specific enhancement of allergy. In vitro effects of Bordetella pertussis vaccine on IgE synthesis. Allergy 1983: 38: 239-46.
41. SEN D, ARORA S, GUPTA S, SANYAL R. Studies of adrenergic mechanisms in relation to histamine sensitivity in children immunized with Bordetella pertussis vaccine. J Allergy Clin Immunol 1974: 54: 25-31.
42. HEDENSKOG S, BJÖRKSTÉN B, BLENNOW M, GRANSTRÖM G, GRANSTRÖM M. Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. Int Arch Allergy Appl Immunol 1989: 89: 156-61.
43. BLENNOW M, GRANSTRÖM M, BJÖRKSTÉN B. Immunoglobulin E response to pertussis toxin after vaccination with acellular pertussis vaccine. In: Manclark CR, ed. Proceedings of the Sixth International Symposium on Pertussis. Bethesda, Maryland: Department of Health and Human Services, United States Public Health Service, 1990: 184-8.
44. VON MUTIUS E, MARTINEZ FD, FRITZSCH C, NICOLAI T, REITMEIR P, THIEMANN HH. Skin test reactivity and number of siblings. Br Med J 1994: 308: 692-5.
45. STRACHAN D. Hay fever, hygiene and household size. Br Med J 1989: 289: 1259-60.
46. BRÅBÄCK L, BREBOROWICZ A, JULGE K, et al. Risk factors for respiratory symptoms and astopic sensitization in the Baltic area. Arch Dis Child 1995: 72: 487-93.
47. HOLT PG. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 1994: 344: 456-8.
48. MIDTVEDT A-C. The establishment and development of some metabolic activities associated with the intestinal microflora in healthy children. Stockhohn, Sweden: 1994, Thesis.
49. SEPP E, JULGE K, VASAR M, NAABER P, BJÖRKSTÉN B, MIKELSAAR M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997: In press.
50. BULLEN C, TEARLE P, WILLIS A. Bifidobacteria in the intestinal tract of infants: an in vivo study. J Med Microbiol 1976: 9: 325-33.